-
Will Trump’s tariff climbdown save the US from recession?
Markets cheered the deal with China. But away from Wall Street, confidence is plummeting and prices are on the rise.
-
Apple’s India migration in the context of US-China tariffs war
What does Apple’s migration to India for manufacturing purposes tell us about the US-China trade war, and what does the future hold for all three countries?
-
Joe Stephenson and Paul Nightingale of Shoosmiths talk tariffs and tech
Joe (above left) and Paul discuss the likely impact of Trump’s tariff policy on the tech sector.
-
Strategic paths for pharma in a tariff-driven world
From short-term moves to long-term manufacturing bets, global reforms are still needed to stabilize the system.
-
How tariffs are reshaping the US pharmaceutical industry
President Trump’s broad 10% tariff push spares pharma for now, but global supply chains may not stay immune.
-
Indian pharma faces challenge from Trump tariffs and US regulators
The US is the third largest importer of drugs made in India. But President Trump’s tariffs plan could derail bilateral trade ties.
-
GRIP Extra: SEC updates marketing rule FAQs, Swiss fine for Lara Warner
Other news includes Chat GPT hallucinates murder, DOGE access to social security data blocked and Tornado Cash no longer sanctioned.
-
GRIP Extra: Pro-labor US labor secretary in, Nasdaq shuts down high speed trading service
Other news includes a $1b Salesforce investment in Singapore, the EU removing four Russian from sanctions list due to Hungarian pressure, and French publishers suing Meta over AI models.